{"id":16467,"type":"page","link":"https:\/\/www.ortaakarsu.net\/?page_id=16467","title":{"rendered":"Osimertinib + Zofran 8 mg"},"content":{"rendered":"<p>Source-based drug interaction information. Detailed information is available with page access.<\/p>","protected":true},"excerpt":{"rendered":"<p>Source-based drug interaction information. Detailed information is available with page access.<\/p>","protected":true},"ism_preview":{"drugs":[{"title":"Osimertinib","url":"https:\/\/www.ortaakarsu.net\/?ism_drug=osimertinib","facts":[{"label":"Active ingredient \/ generic name","value":"osimertinib"}]},{"title":"Zofran 8 mg (Turkish record)","url":"https:\/\/www.ortaakarsu.net\/?ism_drug=zofran-8-mg","facts":[{"label":"Active ingredient \/ generic name","value":"Ondansetron"},{"label":"ATC code","value":"A04AA01"}]}],"record":[{"label":"Record type","value":"Published interaction record"},{"label":"Source record version","value":"DailyMed TAGRISSO SPL v37, effective 2026-09-14; checked 2026-11-04; 5.2 and 7.3"}],"sources":[{"label":"TAGRISSO (osimertinib) \u2014 US prescribing information","url":"https:\/\/dailymed.nlm.nih.gov\/dailymed\/drugInfo.cfm?setid=5e81b4a7-b971-45e1-9c31-29cea8c87ce7"},{"label":"Supporting reference identified in reviewed research","url":"https:\/\/dailymed.nlm.nih.gov\/dailymed\/fda\/fdaDrugXsl.cfm?setid=dafe875e-391f-47a2-97b7-89840a760e44&type=display"}],"reviewed_at":"2026-11-04"},"ism_access":{"required":true,"resource_key":"pair:36178","available":true}}